1. Preface {#sec1-viruses-10-00085}
==========

*Caenorhabidtitis elegans* is a free living nematode found in soil, compost pits and rotting fruits. It was brought from the field to the lab by Sydney Brenner over 50 years ago \[[@B1-viruses-10-00085]\] and has been used to address many fundamental biological questions. For example, the Caspase cell death pathway \[[@B2-viruses-10-00085]\] and RNA interference \[[@B3-viruses-10-00085]\] were first described in *C. elegans* and were later found to be conserved in many species including humans. There are many key features that have made *C. elegans* such a successful model including: A short lifecycle of approximately three days coupled to a hermaphroditic lifestyle that facilitates genetics; transparency of the body that enables live fluorescent imaging studies; a completely defined developmental cell lineage \[[@B4-viruses-10-00085]\]; facile RNAi screening via readily available whole genome RNAi libraries; it was the first metazoan organism with a completely sequenced genome \[[@B5-viruses-10-00085]\]; availability of many mutants and transgenic animals to the community via the *C. elegans* Genetics Center.

As a differentiated multi-cellular organism, *C. elegans* mimics many aspects of mammalian physiology. Of particular relevance to many host--pathogen interactions is the *C. elegans* intestine, which as in higher eukaryotes, is the route of exposure and entry of many pathogens. The *C. elegans* intestine consists of 20 non-renewable epithelial cells, which make up the majority of its total body mass during development through the young adult stage. A key similarity between the *C. elegans* and human intestine is the presence of polarized epithelial cells with microvilli that are structurally attached to a terminal web composed of actin and intermediate filaments underneath the apical membrane \[[@B6-viruses-10-00085],[@B7-viruses-10-00085]\]. The *C. elegans* intestine functions not only to assimilate nutrients, but also has the added function of detoxifying metabolites and toxins, like the liver in humans. It also consists of the first line of defense to invading pathogenic microbes. The intestinal lumen consists of the second-largest surface area in contact with the environment, besides the outer surface cuticle of the *C. elegans* body.

Here, we review host--microbial interactions in *C. elegans* with a focus on those that occur in the intestine.

2. The *C. elegans* Microbiome {#sec2-viruses-10-00085}
==============================

In nature *C. elegans* lives in a complex environment, feeding on bacteria and fungi that are present in soil, compost and rotting fruits. Given this high degree of exposure to microbes, it is likely that in the wild, the *C. elegans* intestine may be populated by many different micro-organisms. In one study, 18 species of bacteria were identified in the microbiota of *C. elegans* that had been fed on soil and rotting fruits \[[@B8-viruses-10-00085]\]. Furthermore, they found that the natural microbiota conferred protection from pathogenic *P. aeruginosa* infection. In 2016, three groups published papers characterizing the natural microbiome of *C. elegans* and found very similar habiting bacteria species in the *C. elegans* intestine from geographically different samples over the world \[[@B9-viruses-10-00085],[@B10-viruses-10-00085],[@B11-viruses-10-00085],[@B12-viruses-10-00085]\]. The natural microbiome studied was shown to improve *C. elegans* growth, resistance to stress and relief from pathogenic bacteria and fungi infections. These observations parallel recent results in the mouse, demonstrating that "wild" microbiota provide a fitness advantage and increased resistance to environmental and infectious insults \[[@B13-viruses-10-00085]\].

3. Bacteria--Host Interactions in the *C. elegans* Gut {#sec3-viruses-10-00085}
======================================================

Since most of the earliest studies of pathogen--host interactions in the *C. elegans* model focused on bacteria, it is natural that there are many reviews on this topic ([Figure 1](#viruses-10-00085-f001){ref-type="fig"}) \[[@B7-viruses-10-00085],[@B14-viruses-10-00085],[@B15-viruses-10-00085],[@B16-viruses-10-00085],[@B17-viruses-10-00085],[@B18-viruses-10-00085]\]. We will focus specifically on the intestinal response of *C. elegans* to pathogen infections ([Table 1](#viruses-10-00085-t001){ref-type="table"}).

In general terms, there are two major, non-mutually exclusive, mechanisms of bacterial pathogenesis in *C. elegans*. One is through secretion of toxins and the other is through direct colonization of the *C. elegans* gut lumen. Examples of both of these mechanisms are illustrated by studies using the well-established *Pseudomonas aeruginosa*-*C. elegans* infection model. The "fast killing" mode is mediated by the bacterial toxin when it is grown on high osmolality rich medium while a "slow killing" mode is observed when bacteria colonize the intestinal lumen \[[@B19-viruses-10-00085]\]. Many bacteria produce or secrete different kinds of toxins to interact with the host that can cause pathophysiological changes to the host. For example, the pore forming toxins produced by *Baccillus thyrogensis* can perforate the *C. elegans* intestinal membrane, causing intestinal distention and animal death \[[@B53-viruses-10-00085],[@B54-viruses-10-00085]\]. *Yersinia* bacteria encode an insecticidal toxin in a gene, *tca*A, which is genetically required for its toxicity to *C. elegans* \[[@B55-viruses-10-00085]\]. *Burkholderia* also produce toxins to kill *C. elegans* \[[@B56-viruses-10-00085],[@B57-viruses-10-00085]\]. *Enterococcus faecalis* express cytolysin that will lyse the host cells of infected *C. elegans* \[[@B58-viruses-10-00085]\]. *Serratia marcescens* infection is also thought to kill by a toxin, suggested by genetic studies to be hemolysin \[[@B24-viruses-10-00085]\]. Studies using *Staphylococcus aureus* showed that secreted α-hemolysin can lyse *C. elegans* cells just as it can lyse mammalian cells \[[@B25-viruses-10-00085],[@B26-viruses-10-00085]\]. *Streptococcus* *pyogenes* and other *Streptococcus* species can synthesize hydrogen peroxide which is sufficient to kill the infected *C. elegans* \[[@B27-viruses-10-00085]\]. Many of these toxin producing bacteria also exert pathogenic effects on *C. elegans* via colonization of the intestinal lumen. By contrast, *Listeria monocytogenes* does not appear to produce any toxins and causes *C. elegans* death exclusively through its accumulation in the *C. elegans* intestine \[[@B59-viruses-10-00085]\].

In the face of these pathogenic bacteria, *C. elegans*, like all hosts, has evolved multiple layers of defenses. At the organismal level, a behavioral response to avoid specific bacterial pathogens has been described \[[@B60-viruses-10-00085],[@B61-viruses-10-00085]\]. In addition, *C. elegans* has physical defenses such as the pharynx grinder that disrupts most bacterial and the intestinal membrane that serves as a barrier to infection \[[@B62-viruses-10-00085]\]. There are also innate immune defense mechanisms that are induced to counteract bacterial infections (model in [Figure 2](#viruses-10-00085-f002){ref-type="fig"}). *C. elegans* expresses different antimicrobial peptides, caenopores, lysozymes, lectins and reactive oxygen species as effector molecules to either detoxify the bacteria toxins or directly kill the invading bacteria (reviewed in \[[@B16-viruses-10-00085],[@B63-viruses-10-00085]\]). A central question that has attracted significant scrutiny, but remains elusive, is the identity of the *C. elegans* pattern recognition receptor(s) (PRR) responsible for detecting bacterial infection. C-type lectins and chemoreceptors were proposed to be *C. elegans* pathogen recognition receptors based on their importance in recognition of pathogen associated molecular patterns (PAMPs) in other organisms \[[@B64-viruses-10-00085],[@B65-viruses-10-00085]\]. It is also possible that detection relies on sensing perturbations of core host processes (also referred to as effector triggered immunity or damage associated molecular patterns (DAMPs)) induced by bacterial toxins \[[@B66-viruses-10-00085]\]. In contrast to the uncertainties associated with the pathogen recognition step, the signaling cascades downstream of recognition have been extensively characterized. The canonical p38 PMK-1 (P38 Map Kinase-1) MAP (Mitogen-Activated Protein) kinase pathway is critical in *C. elegans* for defense against many bacterial infections as well as eukaryotic pathogens \[[@B20-viruses-10-00085],[@B23-viruses-10-00085],[@B67-viruses-10-00085],[@B68-viruses-10-00085],[@B69-viruses-10-00085],[@B70-viruses-10-00085]\]. Other pathways including the TGFβ/DBL-1 (Transforming Growth Factor β/Decapentaplegic/Bone morphogenic protein like-1) and insulin signaling/DAF-2 (Dauer Formation abnormal-2) pathways have also been reported to be involved in the response to bacterial infections \[[@B71-viruses-10-00085]\]. The G-protein coupled lectin like receptor FSHR-1 (Follicle Stimulating Hormone Receptor-1) was shown to be required for immune response during *P. aeruginosa* infection in *C. elegans* intestine \[[@B21-viruses-10-00085]\]. A number of key transcription factors that regulate bacterial pathogen response have been reported, including the ZIP-2/ATFS-1 (bZIP transcription factor-2/Activating Transcription Factor associated with Stress-1) bZIP (Basic Leucine Zipper) transcription factors \[[@B22-viruses-10-00085],[@B72-viruses-10-00085]\], DAF-16 FOXPO (Forkhead box protein O) transcription factors \[[@B73-viruses-10-00085]\], GATA transcription factor ELT-2 (Erythroid-Like Transcription factor-2) \[[@B74-viruses-10-00085]\] and the TFEB/HLH-30 (Transcription factor EB/Helix Loop Helix-30) transcription factors \[[@B75-viruses-10-00085]\].

4. Fungi--Host Interactions in the *C. elegans* Gut {#sec4-viruses-10-00085}
===================================================

*N. parisii*, a natural microsporidial pathogen of *C. elegans*, was discovered in 2008 \[[@B6-viruses-10-00085]\]. *N. parisii* was the first intracellular pathogen of the *C. elegans* intestine to be identified, in contrast to the previously studied bacterial pathogens which colonize in the intestinal lumen but generally do not infect the intestinal cells. Microsporidia infection significantly alters the *C. elegans* intestinal structure \[[@B6-viruses-10-00085],[@B28-viruses-10-00085],[@B29-viruses-10-00085]\]. During the microsporidia lifecycle, meronts form inside the infected *C. elegans* intestinal cells and then exit the infected cells non-lytically by remodeling the intestinal terminal web \[[@B30-viruses-10-00085]\]. In analyzing the transcriptional response of *C. elegans* to *N. parisii* infection, multiple Skr-Cullin-F-box protein ubiquitin ligase components were found to be highly upregulated. The cullin *cul-6* and Skp-1-related genes, *skr-3, 4, 5* were found to be important for ubiquitin targeting of *N. parisii* to the autophagy and proteasome degradation pathways \[[@B29-viruses-10-00085]\].

The opportunistic human pathogen *Candida albicans* can infect the *C. elegans* intestine. Pukkila-Worley et al. established a model infection system in *C. elegans* to understand the host factors that control susceptibility to candidiasis \[[@B31-viruses-10-00085]\]. They found that the yeast form of *C. albicans* can infect intestinal cells and cause distal intestinal distention. By contrast, heat killed *C. albicans* are avirulent, suggesting that the pathogenesis is not mediated by toxins. Analysis of the transcriptional response demonstrated that both live and heat killed *C. albicans* induced a similar response suggesting the host response is meditated by recognition of a fungal motif that is not dependent on growth. As the host response to *C. albicans* infection showed minimal overlap with the responses to pathogenic bacteria such as *S. aureus* and *P. aeruginosa* \[[@B31-viruses-10-00085]\], it appears that *C. elegans* can distinguish between the invading pathogens and mount distinct transcriptional responses to different pathogens.

In contrast to what is observed with Candida, both live and heat killed *Cryptococcus neoformans* are lethal for *C. elegans*, suggesting that the pathogen kills the host by production of virulence factors \[[@B32-viruses-10-00085],[@B33-viruses-10-00085]\].

Other natural fungal pathogens of *C. elegans*, such as *Drechmeria coniospora*, that infect the cuticle rather than the intestine have also been studied \[[@B76-viruses-10-00085]\]. A host G-protein coupled receptor, DCAR-1 (Dihydrocaffeic Acid Receptor-1), was found to regulate the antifungal response by binding to an endogenous ligand \[[@B77-viruses-10-00085]\]; the classic p-38 MAP Kinase PMK-1 pathway is implicated in downstream steps.

5. Virus--Host Interactions in the *C. elegans* Gut {#sec5-viruses-10-00085}
===================================================

From its initial establishment as a model until earlier this decade, there were no known viruses that could naturally infect *C. elegans*. Therefore, the first studies of virus--host interactions in *C. elegans* relied upon surrogate systems that included analysis of *C. elegans* cells, artificial infection conditions, or replicons \[[@B78-viruses-10-00085],[@B79-viruses-10-00085]\]. Specifically, these entailed studies of vesicular stomatitis virus (VSV) infection of primary *C. elegans* cell culture \[[@B34-viruses-10-00085],[@B35-viruses-10-00085]\], artificial virus infection in *C. elegans* using vaccinia virus \[[@B37-viruses-10-00085]\], and a flock house virus transgenic system \[[@B38-viruses-10-00085]\] ([Table 1](#viruses-10-00085-t001){ref-type="table"}).

In 2005, two groups published papers using VSV infection of *C. elegans* primary cells. GFP (Green Fluorescent Protein)-encoding strains of VSV virus replicated to higher levels in cells derived from the RNAi deficient mutant *rde-1* and *rde-4* while the replication was inhibited in cells derived from mutants exhibiting enhanced RNAi responses, such as *rrf-3* and *eri-1*, demonstrating that RNAi is antiviral in *C. elegans* \[[@B34-viruses-10-00085],[@B35-viruses-10-00085]\]. In parallel, a flock house virus replicon system was established that similarly identified RNAi as an antiviral pathway in *C. elegans* \[[@B38-viruses-10-00085]\]. The Flock house virus B2 protein acts as an RNAi antagonist by binding double stranded RNA which then prevents Argonaute protein binding \[[@B39-viruses-10-00085]\]. Lu et al. found that the flock house transgenic virus replication in the N2 wild type *C. elegans* was inhibited when the B2 protein was removed from the transgenic system, but replication of this mutant was restored in the *rde-1* RNAi deficient mutant \[[@B38-viruses-10-00085],[@B40-viruses-10-00085]\]. A subsequent RNAi screen identified host factors in the RNAi pathway that are important for the control of virus replication, such as *rde-1*, *rde-4*, *dcr-1*, *rsd-2* and *drh-1* \[[@B40-viruses-10-00085]\]. Both of these approaches were innovative and provided novel insights into the role of RNAi in *C. elegans*; however, there are also limitations to both. For the former, the cumbersome nature of isolating and maintaining embryonic cells \[[@B80-viruses-10-00085],[@B81-viruses-10-00085]\] has precluded widespread use of the primary cell system to interrogate host--virus interactions in *C. elegans*. For the latter approach, replicon systems cannot be used to study multiple aspects of the viral lifecycle, such as viral assembly, egress or transmission.

As an alternative approach, polyethylene glycol (PEG) treatment of *C. elegans* enabled vaccinia virus to enter and then replicate \[[@B37-viruses-10-00085]\]. Mutants in the cell death pathway lacking *ced-3* and *ced-4* were found to be more susceptible to vaccinia virus infection. This study highlighted a non-RNAi pathway that acts to restrict virus infection in *C. elegans*. Interestingly, when using a vaccinia virus that expresses β-galactosidase, the authors found blue X-gal staining in intestine in all infected animals, suggesting that the intestine is the primary site of infection in this model. To date no additional studies have been published using this system.

The first natural virus of *C. elegans* was not discovered until 2011 \[[@B41-viruses-10-00085]\]. Through field sampling of wild nematodes and next-generation sequencing (NGS), three *Caenorhabditis* nematode viruses, Orsay virus, Santeuil virus, and Le Blanc virus, were isolated and identified \[[@B41-viruses-10-00085],[@B42-viruses-10-00085]\]. All three viruses specifically infect intestinal cells \[[@B43-viruses-10-00085]\] and share similar morphological disease symptoms that primarily affected the intestine including convolution of the intestine, loss of gut granules and fusion of intestinal cells \[[@B41-viruses-10-00085]\]. Orsay virus can infect *C. elegans* strains, including the laboratory N2 strain, while Santeuil and Le Blanc virus infect wild *C. Briggsae* strains but not any tested *C. elegans* strains. To date, Orsay virus is still the only known virus that can naturally infect *C. elegans*. Genome characterization showed that these viruses share some similarity to nodaviruses \[[@B44-viruses-10-00085]\]. RNAi pathway mutants such as *rde-1*, *rde-4* and *drh-1*, supported about 100-fold more virus replication than the wild type N2 strain, unambiguously demonstrating that in *C. elegans* RNAi plays a role in antiviral immunity against an authentic *C. elegans* viral pathogen \[[@B41-viruses-10-00085],[@B45-viruses-10-00085],[@B46-viruses-10-00085]\]. While many viruses of plants and animals encode antagonists of the RNAi pathway, there is no evidence to date that Orsay virus encodes an RNAi antagonistic protein \[[@B47-viruses-10-00085]\]. Subsequent studies found that the wild JU1580 *C. elegans* strain from which Orsay virus was initially isolated carries a deletion polymorphism in the *drh-1* gene which makes this strain highly virus-susceptible \[[@B45-viruses-10-00085]\]. Interestingly DRH-1 (Dicer Related Helicase-1) is distantly related to the mammalian protein RIG-I (Retinoic Acid Inducible Gene-I), which plays a critical role in sensing of RNA viruses and subsequently triggering antiviral interferon induction. It appears that DRH-1 shares a conserved function in sensing intracellular viral RNA, but rather than inducing interferon or an interferon-like gene in *C. elegans*, DRH-1 is critical for antiviral RNAi activity. In fact, domain swapping experiments demonstrated that the helicase domain and C-terminal regulatory domain (CTD) of RIG-I could functionally substitute for the corresponding DRH-1 domain in *C. elegans* \[[@B46-viruses-10-00085]\]. Independent of RNAi, a recent genetic screen identified a novel antiviral mechanism that requires CDE-1 (Caffeine Induced Death-1), a terminal uridylyltransferase \[[@B48-viruses-10-00085]\].

Multiple studies have defined the transcriptional response to Orsay virus infection \[[@B29-viruses-10-00085],[@B49-viruses-10-00085],[@B50-viruses-10-00085]\]. Given that Orsay infection is limited to the intestinal cells, these results most likely represent transcriptional changes within the intestine. A particularly noteworthy aspect of these studies is that Orsay virus infection and microsporidial infection by *N. parisii* induced a shared set of genes \[[@B29-viruses-10-00085],[@B50-viruses-10-00085]\]. The *cul-6*, *skr-3* dependent ubiquitin pathway was found to be induced by both pathogens. RNAi knockdown of *cul-6* led to increased Orsay virus infection \[[@B29-viruses-10-00085]\]. In addition, by further comparing the responses of *C. briggsae* to Le Blanc and Santeuil virus infection, a set of evolutionarily conserved nematode genes that respond to virus infection was defined \[[@B50-viruses-10-00085]\]. Intriguingly, the functions of the majority of these genes are currently unknown, so it is not clear whether these are antiviral genes or genes necessary for viral (and potentially microsporidial) proliferation. In this set, multiple paralogs in the *pals* gene family \[[@B82-viruses-10-00085]\], which has undergone significant expansion in *C. elegans* \[[@B83-viruses-10-00085]\], were highly upregulated. While no clear function for any of these genes in relationship to virus infection has been defined, some of these genes have recently been implicated in regulating protein homeostasis \[[@B84-viruses-10-00085]\].

In an effort to define the regulation of the transcriptional response to Orsay virus infection, promoter motif finding yielded a consensus resembling that of the STA-1 (Signal Transducer and Activator-1) transcription factor \[[@B51-viruses-10-00085]\]. STA-1 is orthologous to mammalian STAT1 (Signal Transducer and Activator of Transcription1), which is a key signaling intermediate essential for interferon signaling in mammals. Mutant *C. elegans* lacking STA-1 were more resistant to Orsay infection than WT animals, suggesting that STA-1 acts as a negative regulator of the *C. elegans* antiviral response, in contrast to the positive regulatory role of the mammalian STAT1. Because STAT1 is known to be regulated by phosphorylation, a targeted kinase RNAi screen in *C. elegans* was pursued that identified SID-3 (Systemic RNA Interference Defective-3), a non-receptor tyrosine kinase \[[@B85-viruses-10-00085]\], as a candidate regulator of STA-1 \[[@B51-viruses-10-00085]\]. Strikingly, *sid-3* was simultaneously identified as a gene required for Orsay virus infection through an independent genetic screen \[[@B52-viruses-10-00085]\]. That study also identified another gene, *viro-2*, which is orthologous to human Wiskott Aldrich Syndrome proteins (WASP), as being required for Orsay virus infection. Both of these genes were required for an early stage of Orsay virus infection; thus these genes may play key roles in entry of Orsay virus from the intestinal lumen.

Recently, direct VSV virus particle injection into *C. elegans* animals was demonstrated to lead to virus replication \[[@B36-viruses-10-00085]\], raising the possibility that this strategy could be used to study a wide range of viruses in *C. elegans*. In this study, unique tissue tropism for muscle was observed following VSV injection, demonstrating that virus infection of non-intestinal cells in *C. elegans* is possible. In addition, virus replication was observed in intestinal tissue in *drh-1* mutant background. A limitation of this strategy is the apparent inability of infected animals to transmit infection to other animals, thus requiring direct microinjection of each individual animal to be analyzed.

6. *C. elegans* as a Model to Study Microbial Trans-Kingdom Interactions {#sec6-viruses-10-00085}
========================================================================

To date, only a limited number of studies have attempted to directly study interactions of microbes from more than one kingdom in *C. elegans*. In one study infection by the fungal pathogen *C. albicans* suppressed anti-bacterial response in *C. elegans* \[[@B31-viruses-10-00085]\], suggesting that Candida infected *C. elegans* may be more susceptible to bacterial superinfection. In another study, co-infection with *C. albicans* and many other gram-negative bacteria all showed that secondary infection of bacteria can inhibit the fungal growth \[[@B86-viruses-10-00085],[@B87-viruses-10-00085]\]. With the discoveries of natural bacterial, fungal and viral pathogens of *C. elegans*, it is now possible to further explore potential trans-kingdom interactions. To date, there have been no studies that evaluated potential virus--fungi interactions or virus--bacterial interactions. For example, although it is known that both *N. parisii* and Orsay virus can infect intestinal cells, there have been no published reports evaluating potential interference or synergy in co-infection or superinfection models. Similarly, there are no reports comparing the impact of a "wild" microbiome vs standard OP50 *E. coli* on viral infection. Given the ease with which "germ-free" *C. elegans* can be generated by bleaching, coupled to the ability to readily control which bacterial species it is exposed to, *C. elegans* may be a very attractive model to define the function of the microbiome, and its interactions with the host and other fungal and viral agents.

7. Conclusions {#sec7-viruses-10-00085}
==============

*C. elegans*, as a simple eukaryotic model organism, provides a tremendous opportunity to define fundamental host--microbe interactions. Starting with the pioneering studies of bacterial pathogenesis, there have now been parallel efforts to use this model to elucidate evolutionarily conserved principles of fungal and viral pathogenesis. There is undoubtedly still much to be learned from these individual systems. However, the time is now ripe to also begin using this model to explore the more nuanced and complex world beyond mono-infection, in order to define the relationships and impacts of microbes on each other.
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![Milestones relevant to host-pathogen interaction studies in *C. elegans*.](viruses-10-00085-g001){#viruses-10-00085-f001}

![Known host genes that interact with bacterial, fungi and viruses in *C. elegans* intestinal cells. MAPK: Mitogen-Activated Protein Kinase; FSHR: Follicle Stimulating Hormone Receptor; DAF: Dauer Formation abnormal; ATFS: Activating Transcription Factor associated with Stress; ELT: Erythroid-Like Transcription factor; ZIP: bZIP (basic Leucine Zipper) domain; HLH: Helix Loop Helix; GPCR: G-Protein-Coupled Receptor; SMAD: Sma and Mad proteins from *Caenorhabditis elegans* and *Drosophila*; DRH: Dicer Related Helicase; RDE: RNAi Defective; SID: Systemic RNA Interference Defective; STA: Signal Transducer and Activator.](viruses-10-00085-g002){#viruses-10-00085-f002}

viruses-10-00085-t001_Table 1

###### 

Pathogen--host interaction in the *C. elegans* intestine.

  Kingdoms            Pathogens                                                                                         Infection and Pathogenic Mode                                                                 Host Pathway and Response in the Intestine                                                                                                                                                                                                                                                            Reference(s)
  ------------------- ------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------
  Bacteria            *P. aeruginosa*                                                                                   Feeding; slow killing by colonization and fast killing by toxin                               PMK-1, ZIP-2, FSHR-1 dependent pathways                                                                                                                                                                                                                                                               \[[@B19-viruses-10-00085],[@B20-viruses-10-00085],[@B21-viruses-10-00085],[@B22-viruses-10-00085]\]
  *S. enterica*       Feeding; killing by colonization; LPS as virulence factor                                         PMK-1-dependant programmed cell death pathway                                                 \[[@B23-viruses-10-00085]\]                                                                                                                                                                                                                                                                           
  *S. marcescens*     Feeding; colonization causes distended intestine; LPS and hemolysin as virulence factors          DBL-1/TGF-β pathway                                                                           \[[@B24-viruses-10-00085]\]                                                                                                                                                                                                                                                                           
  *S. aureus*         Feeding; α-hemolysin as virulence factor                                                          SEK-1 and NSY-1 dependent p38 MAP kinase pathway and TFEB mediated transcriptional response   \[[@B25-viruses-10-00085],[@B26-viruses-10-00085]\]                                                                                                                                                                                                                                                   
  *S. pyogenes*       Feeding; colonization; hydrogen peroxide as virulence factor                                      Not analyzed                                                                                  \[[@B27-viruses-10-00085]\]                                                                                                                                                                                                                                                                           
  Fungi               *N. parisii*                                                                                      Feeding; intracellular infection                                                              CUL-6, SKR-3, 4, 5 ubiquitin ligase pathways                                                                                                                                                                                                                                                          \[[@B6-viruses-10-00085],[@B28-viruses-10-00085],[@B29-viruses-10-00085],[@B30-viruses-10-00085]\]
  *C. albicans*       Feeding; colonization;                                                                            PMK-1/p-38 MAPK pathways                                                                      \[[@B31-viruses-10-00085]\]                                                                                                                                                                                                                                                                           
  *C. neoformans*     Feeding; colonization; laccase; polysaccharide capsule and/or melanization as virulence factors   CED-1, C03F11.3 and ABL-1 dependent pathways                                                  \[[@B32-viruses-10-00085],[@B33-viruses-10-00085]\]                                                                                                                                                                                                                                                   
  Viruses             VSV                                                                                               Infection of primary cell culture or microinjection                                           RNA interference                                                                                                                                                                                                                                                                                      \[[@B34-viruses-10-00085],[@B35-viruses-10-00085],[@B36-viruses-10-00085]\]
  Vaccinia virus      PEG permeabilization                                                                              CED-3 and CED-4 Cell death pathways                                                           \[[@B37-viruses-10-00085]\]                                                                                                                                                                                                                                                                           
  Flock house virus   Transgenic initiation of virus replication                                                        RNA interference                                                                              \[[@B38-viruses-10-00085],[@B39-viruses-10-00085],[@B40-viruses-10-00085]\]                                                                                                                                                                                                                           
  Orsay virus         Feeding                                                                                           RNA interference CUL-6 ubiquitin-proteasome degradation; STA-1 repression and CDE-1           \[[@B41-viruses-10-00085],[@B42-viruses-10-00085],[@B43-viruses-10-00085],[@B44-viruses-10-00085],[@B45-viruses-10-00085],[@B46-viruses-10-00085],[@B47-viruses-10-00085],[@B48-viruses-10-00085],[@B49-viruses-10-00085],[@B50-viruses-10-00085],[@B51-viruses-10-00085],[@B52-viruses-10-00085]\]   

PMK: P38 Map Kinase; ZIP: bZIP (basic Leucine Zipper) domain; FSHR: Follicle Stimulating Hormone Receptor; LPS: Lipopolysaccharide; DBL: Decapentaplegic/Bone morphogenic protein like; TGF: Transforming Growth Factor; SEK: SAPK/ERK Kinase; NSY: Neuronal Symmetry; MAP: Mitogen-Activated Protein; TFEB: Transcription factor EB; CUL: Cullin; SKR: Skp1 Related; CED: Cell death; ABL: Abelson Murine Leukemia; VSV: Vesicular Stomatitis Virus; PEG: Polyethylene Glycol; STA: Signal Transducer and Activator; CDE: Caffeine Induced Death.
